Company Overview

Company Overview

Dong Kook Lifescience as a subsidiary company of Dong Kook Pharmaceutical, follows the core values of founder
and the late Chairman Dong Il Kwon, which are Creativity, Harmony and Credibility.

Creativity
Creating highly-added value by
cultivating individuals’ abilities.
Harmony
Building teamwork by harmonizing
each member’s abilities.
Credibility
Something consequently acquired by,
based on Creativity and Harmony,
satisfying customer expectations.
  • 01
    Diagnostic medicine
    Dong Kook Lifescience strives to strategically expand its markets with leading ethical product portfolio, the main driving engine for the company’s growth.
    These include Megaray (Gadopentetate Dimeglumine: MRI contrast media) and Pamiray (Iopamidol : X-ray contrast media) that its API in synthesized by Dong Kook Lifescience and they are also exported to 17 countries including EU, Japan and Asian market.
    With constant development of new products, Dong Kook Lifescience will keep extending markets and products.
  • 02
    Diagnostic medical device
    Dong Kook Lifescience has two medical device categories with Mobile CT and Ultrasound device.
    Mobile CT Phion™ is the nation’s first mobile CT. Phion™ is quick to obtain the image from the scan to image reconstruction with low Dose. It has the superior Image Quality which comes from 360˚ scanning technology.
    Dong Kook’s Ultrasound device manufactured by Samsung Medison is Color Doppler Ultrasound system which enables fast and accurate diagnosis of diseases such as vascular diseases, abdominal organs, thyroid, breast, heart and musculoskeletal system.
  • 03
    Global Network
    Dong Kook Lifescience has build up the global networks in over 17 countries including EU and Japan.
    In 2016, we achieved US$20 Million in overseas sales with API such as Iopamidol (X-ray contrast media), Cilastatin (Antibiotic) and finished products Pamiray (X-ray contrast media), Megaray (MRI contrast media).
    Especially, Dong Kook Lifescience is expanding global networks further with commitment to sustainable development of products that are focused on advanced countries.
  • 04
    Research & Development
    With keen awareness of importance of R&D, Dong Kook Lifescience is dedicated to making continual progress in R&D innovations and continually develops the new products by investing average 5% of total revenue. Our competencies are being focused to secure an unrivalled position in rapidly changing global markets, by conducting technology-intensive, market and customer-centered development project as well as advancing existing expertise and technology.